← FDA ENFORCEMENT
D-0388-2024Class II

Micro Labs Limited

Recalling firm
Micro Labs Limited
Product type
Drug
Status
Terminated
Report date
2024-03-20
Distribution
Puerto Rico, TN, RI
Firm state
N/A
Product quantity
118,080 bottles
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Validation & Qualification
Reason for recall

Failed Stability Specifications: Out of specification for blend uniformity.

Product description

Telmisartan Tablets, USP 40mg, Rx Only, 30 Tablets per bottle, Manufactured by: Micro Labs Limited Goa-403 722, INDIA, Manufactured for: Micro Labs USA Inc., Somerset, NJ 08873, NDC 42571-227-30.

Code / lot info

Lot #s: SFBG024, SFBG025, Exp. 05/31/2024

Other recalls SPEQ maps to Validation & Qualification
2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc2026-07-22Class IIBell Pharmaceuticals, Inc
See all Validation & Qualification recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.